Literature DB >> 22818071

18 years of the Fontan operation at a single institution: results from 771 consecutive patients.

Lindsay S Rogers1, Andrew C Glatz, Chitra Ravishankar, Thomas L Spray, Susan C Nicolson, Jack Rychik, Christina Hayden Rush, J William Gaynor, David J Goldberg.   

Abstract

OBJECTIVES: The aim of this study was to evaluate Fontan peri-operative outcomes for 771 consecutive patients.
BACKGROUND: Since the initial description by Fontan, mortality associated with the Fontan operation has declined substantially. However, postoperative effusions remain a significant challenge. Effusions are a key determinant of postoperative length-of-stay and have been shown to be associated with the development of protein-losing enteropathy and with decreased survival.
METHODS: This study was a single-center, retrospective review of 771 patients who underwent Fontan palliation from 1992 to 2009.
RESULTS: Patients were divided into 3 eras dictated by shift in clinical practice. Overall mortality was 3.5%, 1% since 1996. Importantly, age at Stage II palliation decreased from Era 1 to Era 3 (7.1 vs. 5.9 months; p = 0.0001), whereas age at Fontan increased (1.7 vs. 2.8 years; p = 0.0001). The proportion of patients with prolonged hospital stay (46.7% vs. 8.2% vs. 19.5%, p < 0.001) decreased substantially after Era 1. A diagnosis of hypoplastic left heart syndrome and longer operative support times were associated with prolonged pleural drainage (odds ratio [OR]: 2.17, p < 0.001; OR: 1.2, p = 0.001) and hospital stay (OR: 1.48, p = 0.05; OR: 1.34, p < 0.001). In patients who underwent invasive assessment, higher pulmonary artery pressure was associated with death (OR: 1.37, p < 0.001) and prolonged hospital stay (OR: 1.09, p = 0.019). Pulmonary arterial pressure ≥15 mm Hg was 90% specific for discriminating unfavorable outcomes.
CONCLUSIONS: Mortality in the modern era is rare, whereas postoperative pleural drainage remains the dominant morbidity. Elevated pulmonary artery pressure seems to be a marker of unfavorable outcome. Continued investigation is warranted to determine whether medical interventions or alterations to operative strategy can alter peri-operative results and improve long-term outcomes.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22818071     DOI: 10.1016/j.jacc.2012.05.010

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  33 in total

1.  Center Variation in Chest Tube Duration and Length of Stay After Congenital Heart Surgery.

Authors:  Katherine E Bates; Nicolas L Madsen; Lara Khadr; Zhiqian Gao; Kari Crawford; Michael Gaies; Margaret Graupe; Samuel P Hanke; Anthony M Hlavacek; Evonne Morell; Sara K Pasquali; Jennifer L Russell; Susan K Schachtner; Ronn E Tanel; Adam L Ware; Alaina K Kipps
Journal:  Ann Thorac Surg       Date:  2019-11-21       Impact factor: 4.330

2.  Percutaneous liver biopsy in Fontan patients.

Authors:  Abhay Srinivasan; Anthony K Guzman; Elizabeth B Rand; Jack Rychik; David J Goldberg; Pierre A Russo; Anne Marie Cahill
Journal:  Pediatr Radiol       Date:  2018-11-30

3.  Post-Extubation Inhaled Nitric Oxide Therapy via High-Flow Nasal Cannula After Fontan Procedure.

Authors:  Yuji Tominaga; Shigemitsu Iwai; Sanae Yamauchi; Miyako Kyogoku; Yosuke Kugo; Moyu Hasegawa; Futoshi Kayatani; Kunihiko Takahashi; Hisaaki Aoki; Muneyuki Takeuchi; Kazuya Tachibana; Hiroaki Kawata
Journal:  Pediatr Cardiol       Date:  2019-05-07       Impact factor: 1.655

4.  Risk Factors for an Elevated Ventricular End-Diastolic Pressure Prior to the Fontan Operation.

Authors:  Matthew C Schwartz; Michael A Brock; David Nykanen; William DeCampli
Journal:  Pediatr Cardiol       Date:  2017-11-27       Impact factor: 1.655

5.  Intermediate-Term Results After Extracardiac Conduit Fontan Palliation in Children and Young Adults with Single Ventricle Physiology-A Single-center Experience.

Authors:  Shashi Raj; Eliot Rosenkranz; Barbara Sears; Sethuraman Swaminathan
Journal:  Pediatr Cardiol       Date:  2016-05-09       Impact factor: 1.655

6.  Outcomes of total cavopulmonary connection for single ventricle palliation.

Authors:  Minghui Zou; Yanfei Wang; Hujun Cui; Li Ma; Shengchun Yang; Yuansheng Xia; Weidan Chen; Xinxin Chen
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

7.  Factors affecting Fontan length of stay: Results from the Single Ventricle Reconstruction trial.

Authors:  Chitra Ravishankar; Eric Gerstenberger; Lynn A Sleeper; Andrew M Atz; Jeremy T Affolter; Timothy J Bradley; J William Gaynor; Bryan H Goldstein; Heather T Henderson; Jeffrey P Jacobs; Alan B Lewis; Carolyn Dunbar-Masterson; Shaji C Menon; Victoria L Pemberton; Christopher J Petit; Nancy A Pike; Christian Pizarro; Kurt R Schumacher; Ismee A Williams; Jane W Newburger
Journal:  J Thorac Cardiovasc Surg       Date:  2015-09-28       Impact factor: 5.209

8.  Analysis of Inflammatory Cytokines in Postoperative Fontan Pleural Drainage.

Authors:  Stephanie A Goldstein; Asaad G Beshish; Lauren B Bush; Ray E Lowery; Joshua H Wong; Kurt R Schumacher; Nadine L N Halligan; Timothy T Cornell; Albert P Rocchini
Journal:  Pediatr Cardiol       Date:  2019-02-01       Impact factor: 1.655

9.  Cumulative radiation exposure in pediatric patients with congenital heart disease.

Authors:  Mark A Walsh; Michelle Noga; Jennifer Rutledge
Journal:  Pediatr Cardiol       Date:  2014-08-15       Impact factor: 1.655

10.  Tricuspid Atresia with Non-compaction: An Early Experience with Implications for Surgical Palliation.

Authors:  Hoang H Nguyen; Rabia Khan; Norman H Silverman; Gautam K Singh
Journal:  Pediatr Cardiol       Date:  2016-12-10       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.